Frontiers in Cell and Developmental Biology · 2023 · 11 citations · 26 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyImmuno-oncology BiomarkersImmunotherapy For Oral CancerOral Cancer PathologyT Cell Responses To TumorsTumor-associated MacrophagesB7 Family Immunoregulatory LigandsImmune Landscape MappingImmune Landscape ProfilingImmunology Of Oral CancerOral Squamous Cell Carcinoma DiagnosisPd-l1 BlockadeTumor Microenvironment Characterization
Background: We previously reported that stroma cells regulate constitutive and inductive PD-L1 (B7-H1) expression and immune escape of oral squamous cell carcinoma. ICOSLG (B7-H2), belongs to the B7 protein family, also participates in regulating T cells activation for tissue homeostasis via binding to ICOS and inducing ICOS + T cell differentiation as well as stimulate B-cell activation, while it appears to be abnormally expressed during carcinogenesis. Clarifying its heterogeneous clinical expression pattern and its immune landscape is a prerequisite for the maximum response rate of ICOSLG-based immunotherapy in a specific population. Methods: This retrospective study included OSCC tissue samples (n = 105) to analyze the spatial distribution of ICOSLG. Preoperative peripheral blood samples (n = 104) and independent tissue samples (n = 10) of OSCC were collected to analyze the changes of immunocytes (T cells, B cells, NK cells and macrophages) according to ICOSLG level in different cellular contents. Results: ICOSLG is ubiquitous in tumor cells (TCs), cancer-associated fibroblasts (CAFs) and tumor infiltrating lymphocytes (TILs). Patients with high ICOSLGTCs or TILs showed high TNM stage and lymph node metastasis, which predicted a decreased overall or metastasis-free survival. This sub-cohort was featured with diminished CD4 + T cells and increased Foxp3+ cells in invasive Frontier in situ , and increased absolute numbers of CD3 + CD4 + and CD8 + T cells in peripheral blood. ICOSLG also positively correlated with other immune checkpoint molecules (PD-L1, CSF1R, CTLA4, IDO1, IL10, PD1). Conclusion: Tumor cell-derived ICOSLG could be an efficient marker of OSCC patient stratification for precision immunotherapy.
26
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling · 2013 · 15.9K citations · Full text
Medicine, Bioinformatics, Oncology +17
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
Shengdian Wang, Gefeng Zhu, Andrei I. Chapoval et al. · Blood · 2000 · 248 citations
Julien Faget, Nathalie Bendriss‐Vermare, Michael Gobert et al. · Cancer Research · 2012 · 210 citations · Full text
Life Sciences, Immunology, Oncology +17